Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients

Anticancer Research

Volumn 22, Issue 6 B, 2002, Pages 3701-3708

  Zambelli, Alberto ^a,c   Montagna, Daniela ^b   Da Prada, Gian Antonio ^a   Maccario, Rita ^b   Zibera, Carlo ^a   Moretta, Antonia ^b   Ponchio, Luisa ^a   Lozza, Laura ^a   Baiardi, Paola ^c   Maserati, Renato ^d   Marone, Pietro ^d   Robustelli della Cuna, Gioacchino ^a  

^a Divisione di Oncologia Medica   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c IRCCS   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Breast cancer; High dose chemotherapy; Infectious complications; Stem cells transplantation

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; ANTINEOPLASTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUCONAZOLE; MELPHALAN; MITOXANTRONE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TEICOPLANIN; THIOTEPA; VANCOMYCIN;

ADULT; ARTICLE; AUTOTRANSPLANTATION; BLOOD; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CELL FUNCTION; CELL TRANSFER; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG FORMULATION; DRUG MEGADOSE; EVALUATION; FEMALE; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFECTION; MAJOR CLINICAL STUDY; METASTASIS; MORBIDITY; PRIORITY JOURNAL; PROLYMPHOCYTE; PROPHYLAXIS; RETROSPECTIVE STUDY; STAPHYLOCOCCUS; STEM CELL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACTEREMIA; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNITY, CELLULAR; MIDDLE AGED; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDIES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; VIRUS ACTIVATION;

EID: 0036875487     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Coleman RE: High-dose chemotherapy: rationale and results in breast carcinoma. Cancer 88: 3059-3064, 2000.
2. Meyers JD: Infection of bone marrow transplant recipient. Am J Med 81 (Suppl. 1A): 27-38, 1986.
3. Salazar R, Sola C, Maroto P, Tabernero JM, Brunet J, Verger G, Valenti V, Cancelas JA, Ojeda B, Mendoza L, Rodriguez M, Montesinos J, Lopez-Lopez JJ et al: Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 23: 27-33, 1998.
4. Kruger W, Russmann B, Kroger N, Salomon C, Ekopf N, Elsner HA, Kaulfers PM, Mack D, Fuchs N, Durken M, Kabisch H, Erttmann R and Zander AR: Early infections in patients undergoing bone marrow or blood stem cell tranplantation: a 7-year single centre investigation of 409 cases. Bone Marrow Transplant 23: 589-897, 1999.
5. Gilbert C, Meisenberg B, Vredenburgh J, Ross M, Hussein A, Perfect J and Peters WP: Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support. J Clin Oncol 12: 1005-1011, 1994.
6. Stable CA and Donowitz GR: Infections in bone marrow transplant recipients. Clin Infect Dis 18: 273-281, 1994.
7. Schuchter LM, Wingard JR, Piantadosi S, Burns WH, Santos FW and Saral R: Herpes zoster infection after autologous bone marrow transplantation. Blood 74(4): 1424-7, 1989.
8. Meyers JD, Flournoy N and Thomas ED: Infection with herpes simplex virus and cell-mediated immunity after marrow transplant. J Infect Dis 142: 338-346, 1980.
9. Meyers JD, Flournoy N and Thomas ED: Cell-mediated immunity to varicella-zoster virus after allogeneic marrow transplant. J Infect Dis 141: 479-487, 1980.
10. Wiston DJ, Ho WG and Champlin RE: Cytomegalovirus infections after allogenic bone marrow transplantation. Rev Infect Dis 12(Suppl. 7): S776-S792, 1990.
11. Sullivan KM, Mori M, Sanders J, Siadak M, Witherspoon RP, Anasetti C, Appelbaum FR, Bensinger W, Bowden R and Buckner CD: Late complications of allogeneic and autologous marrow transplantation. Bone Marrow Transplant 10(suppl. 1): 127-134, 1992.
12. Mossad SB, Longworth DL, Goormastic M, Serkey JM, Keys TF and Bolwell BJ: Early infectious complication in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant 18: 265-271, 1996.
13. Storek J, Espono G, Dawson MA, Storer B, Flowers ME and Maloney DG: Low B cell and monocyte counts on day 80 are associated with high infection rates between day 100 and 365 after allogeneic marrow transplantation. Blood 96: 3290-3293, 2000.
14. Storek J, Gooley T, Witherspoon RP, Sullivan KM, Storb R: Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cells counts. Am J Hematol 54: 131-138, 1997.
15. Storek J and Witherspoon RP: Immunologic reconstitution after hematopoietic stem cell transplantation. In: Atkinson K (ed.). Clinical Bone Marrow and Blood Stem Cell Transplantation. Cambridge United Kingdom: Cambridge University Press pp 111-146, 2000.
16. Storek J, Witherspoon RP and Storb R: T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 16: 413-425, 1995.
17. Steingrimsdottir H, Gruber A, Bjorkholm M, Svensson A and Hansson M: Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying diseasee, type of high-dose therapy and infectious complications. Haematologica 85(8): 832-838, 2000.
18. Miller AB, Hoogstraten B, Staquet M and Winkler A: Reporting result of cancer treatment. Cancer 47: 207-214, 1981.
19. Gianni AM, Siena S, Bregni M, Di Nicola M, Orefice S, Cusumano F, Salvadori B, Luini A, Greco M, Zucali R, Rilke F, Zambetti M, Valagussa P and Bonadonna G: Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results. J Clin Oncol 15(6): 2312-2321, 1997.
20. Zibera C, Pedrazzoli P, Ponchio L, Gibelli N, Lanza A, Da Prada GA, Zambelli A, Perotti C, Torretta L, Salvanschi L and Robustelli della Guna G: Efficacy or epirubicin/paclitaxel combination in mobilizing large amounts of hematopoietic progenitor cells in patients with metastatic breat cancer showing optimal response to the same chemotherapy regimen. Haematologica 84(10): 924-929, 1999.
21. Piccinini G, Comolli G, Gemini E, Lilleri D, Gulminetti R, Maccario R, Revello MG and Gerna G: Comparative analyis of human cytomegalovirus-specific CD4+ T cell frequency and lymphoproliferative response in HIV-positive patients. Clin Lab Diagn Immunol 8(6): 1225-1230, 2001.
22. Kolbe K, Domkin D, Derigs HG, Bhakdi S, Huber C and Aulitzky WE: Infectious complications during neutropenia subsequent to peripheral blood stem cell transplanttion. Bone Marrow Transplant 19(2): 143-147, 1997.
23. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Horowitz ME, Magrath IT, Shad AT and Steinberg SM: Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332(3): 143-9, 1995.
24. Roux E, Dumont-Girard F, Starobinski M, Siegrist CA, Helg C, Chapuis B and Roosnek E: Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 96(6): 2299-303, 2000.
25. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J, Rapoport B, Rolston K and Talcott J: The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18(16): 3038-3051, 2000.
26. Barton T, Collis T, Stadtmauer E and Schuster M: Infectious complications the year after autologous bone marrow transplantation or peripheral stem cell transplantation for treatment of breast cancer. Clin Infect Dis 32: 391-396, 2000.
27. Viscoli C, Bruzzi P, Castagnola E, Boni L, Calandra T, Gaya H, Meunier F, Feld R, Zinner S, Klastersky J et al: Factors associated with bacteremia in febrile granulocytopenic cancer patients. Eur J Cancer 30: 430-437, 1994.
28. Engels EA, Ellis CA, Supran SE, Schmid CH, Barza M, Schenkein DP, Koc Y, Miller KB and Wong JB: Early infection in bone marrow transplantation: Quantitative study of clinical factors that affect risk. Clin Infect Dis 28: 256-266, 1999.
29. Offidani M, Corvatta L, Olivieri A, Rupoli S, Frayfer J, Mele A, Manso E, Montanari M, Centurioni R and Leoni P: Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Bone Marrow Transplant 24: 1079-1087, 1999.
30. Momim F and Chanddrasekar PH: Antimicrobial prophylaxis in bone marrow transplantation. Ann Intern Med 123: 205-215, 1995.
31. Reich G, Mapara MY, Reichardt P, Dorken B and Maschmeyer G: Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant 27: 525-529, 2000.